Thursday , August 22 2019
  • Loading stock data...

Home / Health / A drug derived from marijuana just got a big lift that will likely make it the first of its kind to get federal approval

A drug derived from marijuana just got a big lift that will likely make it the first of its kind to get federal approval

By Erin Brodwin

An experimental drug derived from cannabis to treat epilepsy is on the brink of becoming the first of its kind to win US government approval.

The drug is called Epidiolex, and its active ingredient is cannabidiol, or CBD, the compound in marijuana thought to be responsible for many of its therapeutic effects but not linked with a high. No FDA-approved medications currently include a marijuana compound derived from the plant; only one drug that includes lab-produced THC is on the market.

According to new research, CBD appears to help reduce seizures in two of the hardest-to-treat forms of epilepsy, known as Lennox-Gastaut syndrome and Dravet syndrome.

Read more at Business Insider

About admin

Check Also

Cannabis Consumers Want Hollywood To Abandon Marijuana Stereotypes

By Mike Adams If Hollywood plans to capitalize on the average cannabis consumer, a new …

Leave a Reply

Your email address will not be published. Required fields are marked *

CONTACT US
Thank You. We will contact you as soon as possible.
SUBSCRIBE TO OUR NEWSLETTER
* we never share your e-mail with third parties.